ICU‑Recover Box 2.0: smart home monitoring for people after an ICU stay.

The ICU-Recover Box: Using Smart Technology for Monitoring Health Status After ICU Admission Pilot Study 2.0

Not applicable Interventional Leiden University Medical Center · NCT07162948

This pilot tests whether a home ICU‑Recover Box with smart sensors can help people recovering from an ICU stay detect problems early and support recovery during the year after discharge.

Quick facts

PhaseNot applicable
Study typeInterventional
Enrollment50 (estimated)
Ages18 Years and up
SexAll
SponsorLeiden University Medical Center Academic / other
Locations1 site (Leiden, South Holland)
Trial IDNCT07162948 on ClinicalTrials.gov

What this trial studies

This single‑center cohort pilot will provide 50 patients discharged from the ICU at Leiden University Medical Center with an ICU‑Recover Box before hospital discharge and follow them for up to 12 months. The Box uses connected sensors and smart technology to capture health data at home and alert clinicians to potential complications or need for earlier ambulatory care. The primary goal is to test feasibility and real‑world use of the devices and data flow in the post‑ICU population who required mechanical ventilation. Study procedures focus on usability, adherence, and whether the technology can reliably signal worsening health that might require escalation.

Who should consider this trial

Good fit: Adults (18+) who were admitted to the LUMC ICU for more than 24 hours, received mechanical ventilation, can use smart technology at home (Wi‑Fi and sufficient comprehension), speak English or Dutch, and are discharged from a LUMC ward to home or an extra‑hospital facility are ideal candidates.

Not a fit: People discharged to another hospital, those receiving palliative care, minors, pregnant or breastfeeding individuals, incapacitated adults, or patients without home internet or unable/unwilling to use smart technology are unlikely to benefit from participation.

Why it matters

Potential benefit: If successful, the technology could help detect complications earlier, support recovery at home, improve quality of life, and reduce health care use and costs.

How similar studies have performed: Remote monitoring programs in other post‑discharge populations have shown promise for early detection and reduced utilization, but applying smart home monitoring specifically for ICU‑acquired weakness is relatively novel and not yet proven.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patient has been admitted to the ICU of the LUMC for \> 24 hours.
* Patient has received mechanical ventilation.
* Patient masters the English or Dutch language.
* Patient is able to use smart technology at home. (i.e. Wi-Fi available, sufficient comprehension of smart technology).
* Patient can be contacted and informed about the ICU-Recover box on one of the clinical wards of the LUMC.
* Patient is discharged from a ward within the LUMC to home or an extra-hospital facility.

Exclusion Criteria:

* Patient is \< 18 years old.
* Patient is pregnant.
* Patient breastfeeds during the course of the study.
* Patient is discharged for palliative care.
* Patient is considered an incapacitated adult.
* Patient is unwilling to sign the informed consent form.
* Patient is discharged to another hospital.

Where this trial is running

Leiden, South Holland

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions ICU Acquired Weaknesssmart technologypost-ICU recoverypost intensive care syndromehealth care utilizationhealth related quality of life
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.